Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients

References

• Cruz-JentoftAJ, SayerAA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi:10.1016/S0140-6736(19)31138-931171417
   PubMed Web of Science ®Google Scholar
• MarzettiE, CalvaniR, TosatoM, et al. Sarcopenia: an overview. Aging Clin Exp Res. 2017;29(1):11–17. doi:10.1007/s40520-016-0704-528155183
   PubMed Web of Science ®Google Scholar
• ShafieeG, KeshtkarA, SoltaniA, AhadiZ, LarijaniB, HeshmatR. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord. 2017;21:2017. doi:10.1186/s40200-017-0302-x
   Web of Science ®Google Scholar
• LiuP, HaoQ, HaiS, WangH, CaoL, DongB. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas. 2017;103:16–22. doi:10.1016/j.maturitas.2017.04.00728778327
   PubMed Web of Science ®Google Scholar
• Cruz-JentoftAJ, BahatG, BauerJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy16930312372
   PubMed Web of Science ®Google Scholar
• ChenLK, WooJ, AssantachaiP, et al. Asian Working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi:10.1016/j.jamda.2019.12.01232033882
   PubMed Web of Science ®Google Scholar
• MorleyJE. Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int. 2016;98(4):319–333. doi:10.1007/s00223-015-0022-526100650
   PubMed Web of Science ®Google Scholar
• MorleyJE. Hormones and Sarcopenia. Curr Pharm Des. 2017;23(30):4484–4492. doi:10.2174/138161282366616112315003227881060
   PubMed Web of Science ®Google Scholar
• LandiF, CalvaniR, CesariM, et al. Sarcopenia: an Overview on current definitions, diagnosis and treatment. Curr Protein Pept Sci. 2018;19(7):633–638. doi:10.2174/138920371866617060711345928595526
   PubMed Web of Science ®Google Scholar
• BlackDM, RosenCJ. Clinical practice. postmenopausal osteoporosis. N Engl J Med. 2016;374(3):254–262. doi:10.1056/NEJMcp151372426789873
   PubMed Web of Science ®Google Scholar
• FinkHA, MacDonaldR, ForteML, et al. Long-Term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: a systematic review. Ann Intern Med. 2019;171(1):37–50. doi:10.7326/M19-053331009947
   PubMed Web of Science ®Google Scholar
• SatoC, MiyakoshiN, KasukawaY, et al. Teriparatide and exercise improve bone, skeletal muscle, and fat parameters in ovariectomized and tail-suspended rats. J Bone Miner Metab. 2021;39(3):385–395. doi:10.1007/s00774-020-01184-033392725
   PubMed Web of Science ®Google Scholar
• CangussuLM, Nahas-NetoJ, OrsattiCL, Bueloni-DiasFN, NahasEA. Effect of vitamin D supplementation alone on muscle function in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial. Osteoporos Int. 2015;26(10):2413–2421. doi:10.1007/s00198-015-3151-925956283
   PubMed Web of Science ®Google Scholar
• ParkJH, ParkKH, ChoS, et al. Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women. Menopause. 2013;20(7):747–753. doi:10.1097/GME.0b013e31827cabca23511701
   PubMed Web of Science ®Google Scholar
• LiuM, GuoL, PeiY, et al. Efficacy of zoledronic acid in treatment of osteoporosis in men and women-a meta-analysis. Int J Clin Exp Med. 2015;8(3):3855–3861.26064284
   PubMed Web of Science ®Google Scholar
• DrakeMT, ClarkeBL, KhoslaS. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83(9):1032–1045. doi:10.4065/83.9.103218775204
   PubMed Web of Science ®Google Scholar
• HainBA, JudeB, XuH, et al. Zoledronic Acid Improves Muscle Function in Healthy Mice Treated with Chemotherapy. J Bone Miner Res. 2020;35(2):368–381. doi:10.1002/jbmr.389031614017
   PubMed Web of Science ®Google Scholar
• EssexAL, PinF, HuotJR, BonewaldLF, PlotkinLI, BonettoA. Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice. Front Endocrinol (Lausanne). 2019;10:809. doi:10.3389/fendo.2019.0080931803146
   PubMed Web of Science ®Google Scholar
• CurtisE, LitwicA, CooperC, DennisonE. Determinants of Muscle and Bone Aging. J Cell Physiol. 2015;230(11):2618–2625. doi:10.1002/jcp.2500125820482
   PubMed Web of Science ®Google Scholar
• GrecoEA, PietschmannP, MigliaccioS. Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly. Front Endocrinol. 2019;10:255. doi:10.3389/fendo.2019.00255
   PubMed Web of Science ®Google Scholar
• BoonenS, BlackDM, Colón-EmericCS, et al. Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc. 2010;58(2):292–299. doi:10.1111/j.1532-5415.2009.02673.x20070415
   PubMed Web of Science ®Google Scholar
• KirkB, FeehanJ, LombardiG, DuqueG. Muscle, Bone, and Fat Crosstalk: the Biological Role of Myokines, Osteokines, and Adipokines. Curr Osteoporos Rep. 2020;18(4):388–400. doi:10.1007/s11914-020-00599-y32529456
   PubMed Web of Science ®Google Scholar
• ChiuHC, ChiuCY, YangRS, ChanDC, LiuSH, ChiangCK. Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation. J Cachexia Sarcopenia Muscle. 2018;9(3):585–602. doi:10.1002/jcsm.1228929512306
   PubMed Web of Science ®Google Scholar
• YoonSH, SugamoriKS, GrynpasMD, MitchellJ. Positive effects of bisphosphonates on bone and muscle in a mouse model of Duchenne muscular dystrophy. Neuromuscul Disord. 2016;26(1):73–84. doi:10.1016/j.nmd.2015.09.01526494410
   PubMed Web of Science ®Google Scholar